Common Shares
Preferred Stock Purchase Rights
Preferred Shares
Debt Securities
Warrants
Purchase Contracts
Rights
Units
We may offer common shares (including related preferred stock purchase rights), preferred shares, debt securities, warrants, purchase contracts, rights, or units from time to time. We may also offer securities of the types listed above that are convertible or exchangeable into one or more of the other securities so listed. When we decide to sell a particular class or series of securities, we will provide specific terms of the offered securities in a prospectus supplement. The securities offered by us pursuant to this prospectus will have an aggregate offering amount of up to $250,000,000. The securities issued and sold under this prospectus may be offered directly or through underwriters, agents or dealers. The names of any underwriters, agents or dealers will be included in a supplement to this prospectus. This prospectus describes some of the general forms that may apply to these securities and the general manner in which they may be offered. The prices and other terms of the securities issued and sold under this prospectus will be determined at the time of their offering and will be described in a supplement to this prospectus.
Our common shares are listed on the Nasdaq Capital Market under the symbol "ICON". The aggregate market value of our outstanding common shares held by non-affiliates as of December 4, 2025, was $2,867,650, based on 3,455,000 common shares held by non-affiliates and a closing price on the Nasdaq Capital Market of $0.83 on that date. Pursuant to General Instruction I.B.5 of Form F-3, in no event will the aggregate market value of securities sold by us or on our behalf during the 12-calendar month period immediately prior to, and including, the date of any such sale exceed one-third of the aggregate market value of our common shares held by non-affiliates, calculated in accordance with General Instruction I.B.5 of Form F-3 so long as the aggregate market value of our outstanding common shares held by non-affiliates remains below $75 million. As of the date hereof, we have not offered any securities pursuant to General Instruction I.B.5 of Form F-3 during the 12-calendar month period that ends on and includes the date hereof.
**Common Shares**
**Preferred Stock Purchase Rights**
**Preferred Shares**
**Debt Securities**
**Warrants**
**Purchase Contracts**
**Rights**
**Units**
We may offer common shares (including related preferred stock purchase rights), preferred shares, debt securities, warrants, purchase contracts, rights, or units from time to time. We may also offer securities of the types listed above that are convertible or exchangeable into one or more of the other securities so listed. When we decide to sell a particular class or series of securities, we will provide specific terms of the offered securities in a prospectus supplement. The securities offered by us pursuant to this prospectus will have an aggregate offering amount of up to $250,000,000. The securities issued and sold under this prospectus may be offered directly or through underwriters, agents or dealers. The names of any underwriters, agents or dealers will be included in a supplement to this prospectus. This prospectus describes some of the general forms that may apply to these securities and the general manner in which they may be offered. The prices and other terms of the securities issued and sold under this prospectus will be determined at the time of their offering and will be described in a supplement to this prospectus.
Our common shares are listed on the Nasdaq Capital Market under the symbol "ICON". The aggregate market value of our outstanding common shares held by non-affiliates as of December 4, 2025, was $2,867,650, based on 3,455,000 common shares held by non-affiliates and a closing price on the Nasdaq Capital Market of $0.83 on that date. Pursuant to General Instruction I.B.5 of Form F-3, in no event will the aggregate market value of securities sold by us or on our behalf during the 12-calendar month period immediately prior to, and including, the date of any such sale exceed one-third of the aggregate market value of our common shares held by non-affiliates, calculated in accordance with General Instruction I.B.5 of Form F-3 so long as the aggregate market value of our outstanding common shares held by non-affiliates remains below $75 million. As of the date hereof, we have not offered any securities pursuant to General Instruction I.B.5 of Form F-3 during the 12-calendar month period that ends on and includes the date hereof.
<p><strong>Common Shares</strong><br><strong>Preferred Stock Purchase Rights</strong><br><strong>Preferred Shares</strong><br><strong>Debt Securities</strong><br><strong>Warrants</strong><br><strong>Purchase Contracts</strong><br><strong>Rights</strong><br><strong>Units</strong></p><p>We may offer common shares (including related preferred stock purchase rights), preferred shares, debt securities, warrants, purchase contracts, rights, or units from time to time. We may also offer securities of the types listed above that are convertible or exchangeable into one or more of the other securities so listed. When we decide to sell a particular class or series of securities, we will provide specific terms of the offered securities in a prospectus supplement. The securities offered by us pursuant to this prospectus will have an aggregate offering amount of up to $250,000,000. The securities issued and sold under this prospectus may be offered directly or through underwriters, agents or dealers. The names of any underwriters, agents or dealers will be included in a supplement to this prospectus. This prospectus describes some of the general forms that may apply to these securities and the general manner in which they may be offered. The prices and other terms of the securities issued and sold under this prospectus will be determined at the time of their offering and will be described in a supplement to this prospectus.</p><p>Our common shares are listed on the Nasdaq Capital Market under the symbol "ICON". The aggregate market value of our outstanding common shares held by non-affiliates as of December 4, 2025, was $2,867,650, based on 3,455,000 common shares held by non-affiliates and a closing price on the Nasdaq Capital Market of $0.83 on that date. Pursuant to General Instruction I.B.5 of Form F-3, in no event will the aggregate market value of securities sold by us or on our behalf during the 12-calendar month period immediately prior to, and including, the date of any such sale exceed one-third of the aggregate market value of our common shares held by non-affiliates, calculated in accordance with General Instruction I.B.5 of Form F-3 so long as the aggregate market value of our outstanding common shares held by non-affiliates remains below $75 million. As of the date hereof, we have not offered any securities pursuant to General Instruction I.B.5 of Form F-3 during the 12-calendar month period that ends on and includes the date hereof.</p>